Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial

Secondary mitral regurgitation (MR) is common in patients with left heart dysfunction and it is associated with poor outcomes. Findings from the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, pub...

Full description

Saved in:
Bibliographic Details
Main Authors: Kelly H Schlendorf, Jared O’Leary, JoAnn Lindenfeld
Format: Article
Language:English
Published: Radcliffe Medical Media 2020-07-01
Series:US Cardiology Review
Online Access:https://www.uscjournal.com/articleindex/usc.2020.05
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849220311362306048
author Kelly H Schlendorf
Jared O’Leary
JoAnn Lindenfeld
author_facet Kelly H Schlendorf
Jared O’Leary
JoAnn Lindenfeld
author_sort Kelly H Schlendorf
collection DOAJ
description Secondary mitral regurgitation (MR) is common in patients with left heart dysfunction and it is associated with poor outcomes. Findings from the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, published in 2018, suggest that in a subset of people with heart failure with secondary MR that persists despite optimization of guideline-directed medical therapies, there is now a role for percutaneous mitral valve repair using the MitraClip device. Defining which patients are most likely to benefit from MitraClip, and when, requires both a multidisciplinary approach centered on heart failure, as well as a recognition of the need for further research in this area.
format Article
id doaj-art-2658dea05e4b40c199171b88e74c62c1
institution Kabale University
issn 1758-3896
1758-390X
language English
publishDate 2020-07-01
publisher Radcliffe Medical Media
record_format Article
series US Cardiology Review
spelling doaj-art-2658dea05e4b40c199171b88e74c62c12024-12-14T16:02:14ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2020-07-011410.15420/usc.2020.05Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT TrialKelly H Schlendorf0Jared O’Leary1JoAnn Lindenfeld2Vanderbilt University Medical Center, Nashville, TNVanderbilt University Medical Center, Nashville, TNVanderbilt University Medical Center, Nashville, TNSecondary mitral regurgitation (MR) is common in patients with left heart dysfunction and it is associated with poor outcomes. Findings from the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, published in 2018, suggest that in a subset of people with heart failure with secondary MR that persists despite optimization of guideline-directed medical therapies, there is now a role for percutaneous mitral valve repair using the MitraClip device. Defining which patients are most likely to benefit from MitraClip, and when, requires both a multidisciplinary approach centered on heart failure, as well as a recognition of the need for further research in this area.https://www.uscjournal.com/articleindex/usc.2020.05
spellingShingle Kelly H Schlendorf
Jared O’Leary
JoAnn Lindenfeld
Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
US Cardiology Review
title Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
title_full Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
title_fullStr Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
title_full_unstemmed Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
title_short Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
title_sort treatment of secondary mitral regurgitation in heart failure a shifting paradigm in the wake of the coapt trial
url https://www.uscjournal.com/articleindex/usc.2020.05
work_keys_str_mv AT kellyhschlendorf treatmentofsecondarymitralregurgitationinheartfailureashiftingparadigminthewakeofthecoapttrial
AT jaredoleary treatmentofsecondarymitralregurgitationinheartfailureashiftingparadigminthewakeofthecoapttrial
AT joannlindenfeld treatmentofsecondarymitralregurgitationinheartfailureashiftingparadigminthewakeofthecoapttrial